Related Experiment Video
Updated: Aug 16, 2025
11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
8.1K
Primary Breast Angiosarcoma: Comparative Transcriptome Analysis
Andrés Rincón-Riveros1, Jairo De la Peña2, Wilson Rubiano2
1Bioinformatics and Systems Biology Group, Universidad Nacional de Colombia, Bogotá 111221, Colombia.
International Journal of Molecular Sciences
|December 23, 2022
Summary
This study details a rare primary breast angiosarcoma case in a 55-year-old woman. RNA sequencing revealed a unique genetic profile linked to immune and inflammatory responses, advancing understanding of this aggressive cancer.
Area of Science:
- Oncology
- Genomics
- Immunology
Background:
- Primary breast angiosarcoma is a rare, aggressive cancer (<0.05% of breast neoplasms).
- It presents diagnostic challenges and is often associated with poor prognosis.
- This case involves a de novo primary breast angiosarcoma without prior radiation or lymphedema history.
Observation:
- A 55-year-old woman presented with a rapidly growing, ulcerated, and bleeding left breast mass.
- Immunohistochemistry confirmed angiosarcoma using CD31, CD34, and FLI-1 markers.
- RNA sequencing was performed on tumor and healthy tissues.
Findings:
- The patient's angiosarcoma exhibited a distinct genetic profile compared to public angiosarcoma data.
- This profile showed a significant association with immune and inflammatory response pathways.
- These molecular patterns align with recent findings in angiosarcoma research.
Implications:
- Each case study contributes valuable data to the limited knowledge of angiosarcoma etiology and molecular mechanisms.
- Understanding these pathways is crucial for developing targeted therapies.
- This research highlights the importance of comparative transcriptome studies in rare cancers.
